The Performance of the Mologic Biomarker Panel in Infection

Mologic

Status: Unknown

Conditions: Infection; Sepsis

Treatments: Diagnostic Test: Mologic Biomarker Panel

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT03217552

CN010

Details and patient eligibility

About

This study is a prospective, single center, observational, cohort study of patients to determine whether the Mologic Biomarker Panel can identify patients with infection from those without, including those with other reasons for inflammation (e.g. post-operative). It will also assess whether it has the potential to judge the severity of illness, prognosticate outcome and guide antibiotic therapy.

The aim is to recruit patients who are "representative" of patients with suspected sepsis, uncomplicated infection, or non-infection related critical illness that require critical care intervention and assessment.

This study is observational and will not alter patient management or the standard of care. The results from the investigational Mologic Biomarker Panel and associated research assays will not be provided to treating clinicians, or used in any manner to affect patient care.

The study will take place over approximately an 18-month period and it is anticipated that approximately 600 patients will be collectively enrolled. The study aims to recruit patients from three environments within UCLH:

• The Emergency Department.
• Critical Care Unit
• Patients undergoing major surgery

Enrollment: 600 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ≥ 18 years old
• Investigated for potential infection (the clinical need for a blood culture)

Exclusion criteria

• <18 years old
• Severe anaemia (<60g/dl) and contra-indication to transfusion
• Unable to gain consent or agreement
• Treated with palliative intent
• Blood culture indicated for screening or monitoring

Trial design

600 participants in 3 patient groups

The Emergency Department

Description:

The study aims to evaluate the test in this environment as a potential diagnostic. All patients will be screened using the electronic patient management system within the ED. A single sample of approximately 20ml of blood, will be obtained at the same time as a clinically indicated blood culture (triggered by clinician concern for infection). The sample will be processed as described in the laboratory manual, aliquoted and frozen for future batch analysis. This analysis will include: * The Mologic Biomarker Panel * PCT * CRP * Other inflammatory markers or pathogen detection that may augment the panels accuracy All conventional standard of care testing will be done at the study site as part of the enrolled subject's routine clinical care.

Treatment:

Diagnostic Test: Mologic Biomarker Panel

Critical Care Unit

Description:

Two patient populations admitted to the CCU will be approached for inclusion into the study: * Patients being managed for potential infection * Patients having undergone elective major surgery and admitted to the CCU as part of their care pathway. These patients will act as controls as the majority show signs and symptoms of inflammation but rarely develop an infection. Patients with potential infection: UCLH Critical Care Unit has approximately 1000 emergency admissions per year. Complicated infection (sepsis or septic shock) being the commonest underlying reason for admission.

Treatment:

Diagnostic Test: Mologic Biomarker Panel

Patients undergoing major surgery

Description:

UCLH Critical Care admits approximately 1000 patients per year following major elective surgery. These patients frequently exhibit the features of SIRS but the incidence of infection/sepsis is low (approximately 5%) and very rare in the first 3 days' post-surgery. This group is to be studied as a negative control group to ensure the Mologic Biomarker Panel is able to detect the difference between the similar inflammatory phenotypes developed through infection and surgical trauma.

Treatment:

Diagnostic Test: Mologic Biomarker Panel